Today we are tearing out the last page of the calendar and with it we say goodbye to the old year 2023 (which brought us the war between Hamas and Israel, and also a million good news, such as the publication of Pan-Hispanic Dictionary of Medical Terms) and we welcome the new year 2024. It’s a good time to look back and take a quick review of what our year just ended has to say about itself. Language Laboratory,
Here is a possible selection of the twenty most notable entries that I will be publishing in different sections of the blog this year,
For bread, bread: “Food and Nutrition” (26 September)
Historical and literary quotes: ,on his dead chest(19 October)
Medical-linguistic curiosities: «Aptonyms (and II)» (4 November)
Where does it come from?: ,nystatin» (6 October)
From man to name: ,Petri dish(24 August)
Reasonable Doubt: ,cannabis(17 April)
A spectacular circus of scientific names: “New gene names due to Excel” (January 18)
Power of Language: ,mental retardation(6 May)
Sacred errors (or almost): ,Keep this medicine…” (June 3)
Odd Pairings: “Health and Good Luck” (November 18)
Guest Signature: ,body posture» (July 15) and ,What is a woman?(17 March)
Humor and Language: ,mummy no: mummified person” (April 2)
Patient Jargon: ,Tiredness» (2 November)
Forest of Medical Acronyms,TCE, TCAE, TMSCAE(14 April)
Good Medical Literature: ,awakening (1973)” (4th of July)
Doctors know how to write: ,Mariano Azuela (1873–1952)» (January 1)
English is so difficult! ,aseptic meningitis(26 April)
Do you know…?: ,Doctor Copernicus and Galileo(19 February)
New words: “Anecado” (24 November)
Forgotten words: “Safitas” (16 February)
From Language Laboratory I wish all the followers of the page a prosperous year 2024.
To refresh your memories, here you can find a selection corresponding to the last three years: «Lab 2022: Highlights of the year,LAB 2021: Highlights of the year” And “LAB 2020: Highlights of the year,
-
Clinical laboratory is moving in all directions
Presented by Roche Diagnostics
-
Neurology: Challenges and Strategies for Multiple Sclerosis, Migraine and Parkinson’s
-
Estimates of sleep disorders in Parkinson’s range from 42% to 98%.
Offered by ABBVIE
-
Multiple Sclerosis Today: Early Diagnosis and Treatments That Reduce the Effects of the Disease
proposed by merck
-
Preventing the worsening of migraine is one of the current therapeutic objectives.
Proposed by Lundbeck
-
New therapeutic options for chronic lymphocytic leukemia (CLL), multiple myeloma (MM) and lymphoma.
Offered by Johnson & Johnson
-
the laboratory of the future is here
Presented by Roche Diagnostics
-
CrisVita®, newly funded treatment for X-linked hypophosphatemia (XLH) in adults
KYOWA OFFERED BY KIRIN
-
Most patients who decide to be treated with a higher dose of duloxetine begin treatment directly in this dose range.
Presented by Neuraxpharm
-
Bringing innovation to vulnerable kidney transplant patients
Presented by Hansa Biopharma
-
A health commitment to the climate emergency
Presented by Sigre
-
The importance of innovation to the needs of patients with diffuse large B cell lymphoma and follicular lymphoma.
Presented by Roche